Related Experiment Video
Updated: Apr 24, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Risk-Weighted Impact: Reframing Risk Analyses for Medical Decisions
Zane Schnurman1, Douglas Kondziolka
1Department of Neurosurgery, NYU Langone Health, New York, New York, USA.
Background And Objectives:
Developing precise metrics for clinical use is vital to translating outcomes data to practice. Risk probabilities, such as the complication rate of surgery or the lifetime risk of an aneurysm rupture, are widely used for counseling patients, but their comparison may be misleading if risks are spread over different time horizons. This study evaluates a new risk-assessment approach called risk-weighted impact (RWI) that applies event probabilities to estimate the average number of years of life impacted by event occurrence.
Methods:
Decision-making policies based on RWI and cumulative lifetime event risk were applied to determine management in a simplified model of incidental cerebral aneurysms through Monte Carlo simulation (1000 iterations of 10 000 synthetic patients). In addition, a web-based application was created to simplify risk-assessment calculations and comparisons.
Results:
When treatment of incidental cerebral aneurysms was simulated using both risk assessment methods, there was disagreement in 25.2% (95% CI: 24.4%-26.1%) of cases, with the RWI policy preferring observation, while event-risk policy preferred intervention. In these patients, the number of poor outcomes was nearly the same, 110 (95% CI: 91-129) in RWI policy and 111 (95% CI: 90-132) in event-risk policy, but the RWI policy resulted in 874.8 fewer quality-adjusted life year lost (95% CI: 299.5-1466.6) due to adverse events occurring an average of 11.3 years later (95% CI: 8.2-14.1 years).
Conclusion:
Only using cumulative lifetime event risks may understate the impact of an up-front treatment given that a larger proportion of risk is assumed at an earlier age, when more years of life are in jeopardy. RWI offers an alternative approach to thinking about risk, using the same inputs (event probabilities and life expectancy) to compare estimated patient impact. RWI is more aligned with clinical objectives and is a valuable metric for risk assessment and decision making.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Framing Effects
Hazard Ratio
For example, in a clinical trial...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Relative Risk
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

